Table 3. A multivariate analysis to determine the relationship between the modified LANZA score and independent risk factors.
Variable | Regression coefficient | Standard error | p-value | 95%CI (lower limit) | 95%CI (upper limit) |
---|---|---|---|---|---|
Constant | -0.553 | 0.278 | 0.0471 | -1.098 | -0.00712 |
Age | 0.00515 | 0.00330 | 0.119 | -0.00133 | 0.0116 |
Steinbrocker class | 0.129 | 0.0556 | 0.0202* | 0.0202 | 0.238 |
PSL dose | 0.0381 | 0.0115 | <0.001** | 0.0156 | 0.0606 |
Usage of NSAIDs | 0.279 | 0.0702 | <0.001** | 0.141 | 0.417 |
PPIs | -0.208 | 0.0731 | 0.00455** | -0.351 | -0.0643 |
Gastroprotective drugs | 0.102 | 0.0726 | 0.159 | -0.0402 | 0.244 |
PSL, prednisolone; NSAIDs, non-steroidal anti-inflammatory drugs; PPIs, proton pump inhibitors. Data were analyzed using a multivariate analysis,
*p<0.05,
**p<0.01.